Eterna Therapeutics Inc. (NASDAQ: ERNA)
$2.08
-0.0100 ( -0.48% ) 1.1K
Eterna Therapeutics Inc is a biopharmaceuticals company. The company develops transformational new medicines using various cell engineering technology. It is engaged in developing breakthrough mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. With its strategic partners, the group is developing nucleic acid and cell therapies that can significantly improve the health outcomes of patients with high unmet medical needs.
Market Data
Open
$2.08
Previous close
$2.09
Volume
1.1K
Market cap
$11.25M
Day range
$1.98 - $2.11
52 week range
$0.84 - $2.96
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jun 25, 2024 |
10-q | Quarterly Reports | 77 | May 14, 2024 |
4 | Insider transactions | 1 | Apr 29, 2024 |
4 | Insider transactions | 1 | Apr 29, 2024 |
4 | Insider transactions | 1 | Apr 29, 2024 |
8-k | 8K-related | 13 | Mar 22, 2024 |
10-k/a | Quarterly Reports | 17 | Mar 18, 2024 |
10-k | Annual reports | 113 | Mar 14, 2024 |
8-k | 8K-related | 14 | Feb 16, 2024 |
3 | Insider transactions | 2 | Feb 16, 2024 |